1-6 of 6
Alexander Steinle, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Platelet-Derived Proteases ADAM10 and ADAM17 Impair NK Cell Immunosurveillance of Metastasizing Tumor Cells By Diminishing NKG2D Ligand Surface Expression

Stefanie Raab, MSc, Korbinian Nepomuk Kropp, Alexander Steinle, PhD, Gerd Klein, PhD, Lothar Kanz, MD, Hans-Georg Kopp, MD, Helmut R Salih, MD
Journal: Blood
Blood (2014) 124 (21): 4164.
https://doi.org/10.1182/blood.V124.21.4164.4164
Published: 2014
Journal Articles

Platelets Impair NK Cell Immunosurveillance Of Metastasizing Tumor Cells By Altering Surface Expression and Shedding Of Ligands For The Activating Immunoreceptor NKG2D

Stefanie Raab, Korbinian Nepomuk Kropp, Alexander Steinle, PhD, Lothar Kanz, MD, Hans-Georg Kopp, MD, Helmut R. Salih, MD
Journal: Blood
Blood (2013) 122 (21): 3488.
https://doi.org/10.1182/blood.V122.21.3488.3488
Published: 2013
Journal Articles

Induction of NK Cell Reactivity in Breast Cancer by Fc-Engineered NKG2D-Ig Fusion Proteins

Stefanie Raab, Julia Steinbacher, Ludger Grosse-Hovest, PhD, Benjamin J Schmiedel, PhD, Alexander Steinle, PhD, Lothar Kanz, MD, Helmut R Salih, MD
Journal: Blood
Blood (2012) 120 (21): 253.
https://doi.org/10.1182/blood.V120.21.253.253
Published: 2012
Journal Articles

NKG2D and Its Ligands In Leukemia: Comprehensive Analysis of Expression, Release and Modulation of NK Cell Reactivity.

Julia Hilpert, Maria Zeiser, Lothar Kanz, MD, Tina Baessler, Alexander Steinle, PhD, Helmut R. Salih, MD
Journal: Blood
Blood (2010) 116 (21): 1686.
https://doi.org/10.1182/blood.V116.21.1686.1686
Published: 2010
Journal Articles

Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.

Mercedes Kloss, Patrice Decker, PhD, Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Lothar Kanz, MD, Alexander Steinle, PhD, Helmut R. Salih, MD
Journal: Blood
Blood (2007) 110 (11): 2415.
https://doi.org/10.1182/blood.V110.11.2415.2415
Published: 2007
Journal Articles

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Matthias Krusch, MD, Sorin Armeanu, PhD, Katrin M. Baltz, Ulrich M. Lauer, MD, Alexander Steinle, PhD, Lothar Kanz, MD, Michael Bitzer, MD, Helmut R. Salih, MD
Journal: Blood
Blood (2007) 110 (11): 4181.
https://doi.org/10.1182/blood.V110.11.4181.4181
Published: 2007